Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

P.E.I.’s chief public health officer says the province has decided to pause the establishment of a supervised injection site ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

You’ll administer Mounjaro weekly as a subcutaneous injection ... You can give Mounjaro injections to yourself if you use injection sites that are easy to access. These sites include your ...

The subcutaneous autoinjector, named lecanemab-irmb, is designed as a weekly treatment option for maintenance dosing in patients who have already completed the biweekly intravenous initiation phase.

The reported side-effects of KORTUC have so far been limited to discomfort at the injection site for up to 24 hours. Professor Karol Sikora, a clinical oncologist based in London, is however cautious.

The investigation has enrolled 532 patients with relapsed/refractory myeloma across 252 global sites. Eligible adult patients who ... device that is thinner compared with commonly used subcutaneous ...

Nucala (mepolizumab) is a brand-name subcutaneous injection that comes ... Before injecting Nucala, you’ll need to clean the injection site with an alcohol swab and let it air-dry.